HIV-1 Gag contributes to susceptibility of protease inhibitors (PIs) in the absence of known
resistance mutations in the protease gene. For the majority of HIV-infected patients …

Background: In spite of so many FDA approved HIV drugs, HIV infections and deaths are
increasing across the glob. Thus, HIV research is still important and challenging. Finding of …

Among the HIV-1 capsid inhibitors, PF-74 is by far the most characterized. It has a
multimodal mechanism of action, preventing the uncoating of the capsid core and …

Until now, there are many antiviral drugs on the market but only selected viruses are
targeted. In many cases, drugs are often invented in the aftermath of an outbreak and only …

Human immunodeficiency virus type 1 (HIV-1) infection persists for life, requiring the regular
administration of antiretroviral therapy (ART) to suppress viral replication. Poorly tolerated …

The early and late stages of human immunodeficiency virus (HIV) replication are
orchestrated by the capsid (CA) protein, which self-assembles into a conical protein shell …

Gag es una de las proteínas más conservadas del VIH-1. Se ha demostrado que las
regiones invariables de este antígeno son críticas para la capacidad replicativa viral y la …

TERESA LLÁCER DELICADO ha realizado bajo su dirección en el Laboratorio de
Epidemiología Molecular del VIH-1 del Servicio de Microbiología del Hospital Universitario …

This cross sectional study was aimed at evaluating the response of immune parameters in
HIV positive subjects on antiretroviral therapy in Port Harcourt, Rivers State, Nigeria. A total …